潘尼莫德是S1P1受体选择性口服型激动剂，是治疗多发性硬化（MS）和银屑病的实验药物。
3-Chloro-4-hydroxybenzaldehyde
(2R)-(-)-3-Chloropropane-1,2-diol
(Z)-5-((Z)-3-Chloro-4-((R)-2,3-dihydroxypropoxy)benzylidene)-2-(propylimino)-3-(o-tolyl)thiazolidin-4-one
(S)-(+)-2,2-Dimethyl-1,3-dioxolane-4-methanol
o-Tolylisothiocyanate
Bromoacetyl chloride
(Z)-2-(Propylimino)-3-(o-tolyl)thiazolidin-4-one
